If you wish to receive information about Solbec via email, please enter your email address and a password below, then click subscribe.
Email Address
Password




Solbec Pharmaceuticals Ltd (Solbec) is a biotechnology company committed to the development and commercialisation of better therapies for life threatening and debilitating diseases.

Solbec specialises in late stage research / early-mid stage clinical development of novel and commercially attractive biopharmaceutical compounds for the international market.  Solbec’s lead compound Coramsine® (SBP002) is a two component glycoalkaloid mixture extracted from the fruit of the plant Solanum linnaeanum “The Devil’s Apple”.  Through this one glycoalkaloid platform, multiple proprietary applications potentially exist. 

Key areas of focus include the treatment of cancer, in particular melanoma, renal cell carcinoma and malignant mesothelioma.  The Company is also focused on the treatment of the inflammatory dermal disorder psoriasis. (See "Coramsine® Clinical Development" below).

 

Solbec is headquartered in Perth, Western Australia, and listed on the Australian Stock Exchange (Code SBP).

 

Webmaster Edit


Monday, 19 May 2008

Solbec Strategically Reviews Operations, Working Towards Out-Licensing Opportunities for Coramsine®
Click Here for PDF
MORE...

Tuesday, 22 April 2008

Dr William Ardrey Appointed Chairman
Click Here for PDF
MORE...

Monday, 14 April 2008

Appendix 4C
Click Here for PDF
MORE...

Tuesday, 1 April 2008

Timeout of CommercialReady Grant
Click Here for PDF
MORE...

Tuesday, 1 April 2008

Appendix 3X
Click Here for PDF
MORE...

Friday, 28 March 2008

Solbec Announces Grant of US Patent
Click Here for PDF
MORE...

Wednesday, 26 March 2008

Appointment of Director
Click Here for PDF
MORE...

Monday, 17 March 2008

Final Report Received for Initial Component of Supplementary Preclinical Stuides
Click Here for PDF
MORE...

Friday, 29 February 2008

Half Yearly Report
Click Here for PDF
MORE...

Friday, 29 February 2008

Appendix 4D
Click Here for PDF
MORE...

Monday, 4 February 2008

U.S. Renal Cell Carcinoma Patient Update
Click Here for PDF
MORE...

Thursday, 31 January 2008

Appendix 4C
Click Here for PDF
MORE...

Thursday, 20 December 2007

FINAL DIRECTOR'S INTEREST NOTICE
Click Here for PDF
MORE...

Thursday, 20 December 2007

CHAIRMAN'S RESIGNATION
Click Here for PDF
MORE...

Monday, 10 December 2007

APPENDIX 3Y
Click Here for PDF
MORE...

Monday, 19 November 2007

SOLBEC AGM RESULTS
Click Here for PDF
MORE...

Friday, 26 October 2007

SOLBEC AGM NOTICE OF MEETING
AGM Notice of Meeting
MORE...

Monday, 22 October 2007

SOLBEC SECURES CORAMSINE TRADEMARK IN JAPAN
Solbec secures Coramsine Trademark in Japan
MORE...

Wednesday, 17 October 2007

APPENDIX 4C QUARTERLY REPORT
Appendix 4C 30/09/07
MORE...

Tuesday, 16 October 2007

PHYSICIANS IND APPROVED BY FDA
Physicians IND Approved by FDA
MORE...

Wednesday, 10 October 2007

SUPPLEMENTARY PRECLINICAL STUDIES COMMENCED
Preclinical Studies Commenced
MORE...

Thursday, 27 September 2007

SOLBEC ANNUAL REPORT 2007
Annual Report 2007
MORE...

Thursday, 13 September 2007

APPENDIX 3X
Appendix 3X
MORE...

Thursday, 13 September 2007

APPENDIX 3Y
Appendix 3Y
MORE...

Thursday, 6 September 2007

APPOINTMENT OF NEW DIRECTOR AND ISSUE OF OPTIONS
Appointment of new Director and Issue of Options
MORE...

Thursday, 6 September 2007

APPENDIX 3B
Appendix 3B
MORE...

Friday, 31 August 2007

APPENDIX 4E
Preliminary Final Report
MORE...

Tuesday, 31 July 2007

APPENDIX 4C
Appendix 4C quarterly report
MORE...

Wednesday, 25 July 2007

APPENDIX 3X INITIAL DIRECTORS INTEREST NOTICE
Appendix 3X
MORE...

Tuesday, 24 July 2007

APPOINTMENT OF NEW DIRECTOR
Appointment of New Director
MORE...

Wednesday, 4 July 2007

APPENDIX 3Y CHANGE OF DIRECTORS INTEREST NOTICE
Appendix 3Y
MORE...

Wednesday, 20 June 2007

APPENDIX 3B
Appendix 3B
MORE...

Wednesday, 13 June 2007

CANADIAN GLYCOALKALOID PATENT GRANTED
Canadian Glycoalkaloid Patent Granted
MORE...

Wednesday, 13 June 2007

APPENDIX 3B
Appendix 3B
MORE...

Tuesday, 8 May 2007

TGA APPROVED CORAMSINE DEVELOPMENT PLAN
TGA Approved Coramsine Development Plan
MORE...

Friday, 4 May 2007

NOTICE OF CHANGE OF INTERESTS OF SUBSTANTIAL HOLDER
Substantial shareholder notice
MORE...

Wednesday, 2 May 2007

PROSPECTUS LODGED WITH ASIC
Prospectus Lodged with ASIC
MORE...

Wednesday, 2 May 2007

PROSPECTUS
Prospectus
MORE...

Friday, 27 April 2007

SOLBEC CONFIRMS SHARE PLACEMENT
Solbec Confirms Share Placement
MORE...

Thursday, 26 April 2007

APPENDIX 4C QUARTERLY REPORT 31 MARCH 2007
Appendix 4C
MORE...

Monday, 23 April 2007

APPENDIX 3B NEW ISSUE ANNOUNCEMENT
Appendix 3B
MORE...

Monday, 23 April 2007

SOLBEC ANNOUNCES CAPITAL RAISING
Placement & Rights Issue
MORE...

Friday, 20 April 2007

SOLBEC TRADING HALT
Solbec Trading Halt
MORE...

Monday, 16 April 2007

KEY COMPOSITION OF MATTER PATENT AWARDED IN NEW ZEALAND
Patent for GA Composition & Various Uses Awarded in NZ
MORE...

Wednesday, 28 February 2007

APPENDIX 4D HALF YEAR REPORT
Half year report 311206
MORE...

Tuesday, 6 February 2007

RHAMNOSE BINDING PATENT GRANTED IN NEW ZEALAND
Patent Granted in New Zealand
MORE...

Tuesday, 30 January 2007

APPENDIX 4C
Quarterly Report 31 Dec 2006
MORE...

Thursday, 30 November 2006

APPENDIX 3Y CHANGE OF DIRECTORS INTEREST NOTICE
Appendix 3Y
MORE...

Wednesday, 29 November 2006

UPDATE ON TGA MATTER
Up date on TGA matter
MORE...

Tuesday, 28 November 2006

NOTICE OF AGM AND EXPLANATORY STATEMENT
NOM for AGM
MORE...

Monday, 27 November 2006

SOLBEC AGM 2006 RESULT
AGM Result
MORE...

Wednesday, 22 November 2006

Managing Director resignation
MD resigns
MORE...

Monday, 13 November 2006

SOLBEC POSTPONING PHASE II TRIALS
Phase II trials postponed
MORE...

Tuesday, 31 October 2006

APPENDIX 4C QUARTERLY REPORT
Appendix 4C
MORE...

Tuesday, 31 October 2006

APPENDIX 3Y CHANGE OF DIRECTORS INTEREST NOTICE
Appendix 3Y
MORE...

Thursday, 26 October 2006

RESIGNATION OF SOLBEC DIRECTOR
Director Resignation
MORE...

Wednesday, 13 September 2006

APPENDIX 4E PRELIMINARY FINAL REPORT
Appendix 4E
MORE...

Tuesday, 12 September 2006

SOLBEC FACILITY GMP LICENCE RENEWED
Solbec facility GMP licence renewed
MORE...

Friday, 25 August 2006

APPENDIX 6A
Appendix 6A
MORE...

Friday, 25 August 2006

APPENDIX 3B
Appendix 3B New Issue
MORE...

Thursday, 24 August 2006

SOLBEC SECURES US TRADEMARK CORAMSINE
Secures US Trademark Coramsine
MORE...

Friday, 11 August 2006

APPENDIX 3B NEW ISSUE
Appendix 3B New Issue
MORE...

Friday, 28 July 2006

APPENDIX 4C QUARTERLY REPORT
Appendix 4C
MORE...

Tuesday, 25 July 2006

UPDATE ON SOLBECS ETHICS APPROVAL FOR PHASE II TRIALS
Update on solbecs Ethics Approval for Phase II Trials
MORE...

Tuesday, 18 July 2006

APPENDIX 3Z FINAL DIRECTORS INTEREST NOTICE
Final Directors Interest Notice
MORE...

Thursday, 13 July 2006

Dr David Hung resigns as Director
Director Resignation
MORE...

Wednesday, 21 June 2006

SOLBEC PRESENTS CORAMSINE COMPLETE PHASE I CLINICAL TRAIL RESULTS AT ASCO
Phase I results presented at ASCO 2006
MORE...

Wednesday, 21 June 2006

2006 ASCO Annual Meeting Proceedings, Prof Michael Millward.
Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings Part I. Vol 24, No. 18S (June 20 Supplement), 2006: 2070
MORE...

Tuesday, 13 June 2006

MANAGING DIRECTORS REMUNERATION
Details of Managing Directors Remuneration
MORE...

Tuesday, 6 June 2006

APPENDIX 3Y CHANGE OF DIRECTORS INTEREST NOTICE
Appendix 3Y Change of Directors' Interest Notice
MORE...

Wednesday, 17 May 2006

APPENDIX 3B, NEW ISSUE ANNOUNCEMENT
Appendix 3B, New Issue Announcement
MORE...

Tuesday, 16 May 2006

UPDATE ON SHARE PURCHASE PLAN
Update on Share Purchase Plan
MORE...

Monday, 15 May 2006

SOLBEC APPOINTS DR GRAEME HOWIE AS MANAGING DIRECTOR
Solbec Appoints Dr Graeme Howie as Managing Director
MORE...

Monday, 1 May 2006

SOLBECS RECENT US BIO2006 TRIP
Solbecs recent US BIO2006 Trip
MORE...

Wednesday, 26 April 2006

EXTENSION OF DEADLINE FOR SHARE PURCHASE PLAN
Extension of Deadline for Share Purchase Plan
MORE...

Friday, 21 April 2006

APPENDIX 4C QUARTERLY REPORT
Appendix 4C Quarterly Report
MORE...

Tuesday, 18 April 2006

SOLBEC SHAREHOLDER MEETING REMINDER
Shareholder meeting reminder
MORE...

Wednesday, 12 April 2006

APPENDIX 3Y CHANGE OF DIRECTORS INTEREST NOTICE
Appendix 3Y
MORE...

Friday, 31 March 2006

SOLBEC APPOINTS GENERAL MANAGER
Solbec appoints General Manager
MORE...

Thursday, 30 March 2006

SOLBEC TO PRESENT AT BIO BOSTON AND BIO 2006
Solbec to present at Bio Boston and BIO 2006
MORE...

Tuesday, 28 March 2006

APPENDIX 3Y CHANGE OF DIRECTORS INTEREST NOTICE
Appendix 3Y
MORE...

Monday, 27 March 2006

APPENDIX 3Y CHANGE OF DIRECTORS INTEREST NOTICE
Appendix 3Y
MORE...

Friday, 24 March 2006

SOLBEC ANNOUNCES SHARE PURCHASE PLAN
Solbec announces share purchase plan
MORE...

Thursday, 16 March 2006

APPENDIX 4D HALF YEAR REPORT
Appendix 4D
MORE...

Friday, 17 February 2006

SOLBEC INVESTOR NEWSLETTER
Solbec Investor Newsletter
MORE...

Thursday, 16 February 2006

FDA GRANTS CORAMSINE ORPHAN DRUG STATUS FOR MELANOMA
Click here for PDF
MORE...

Friday, 3 February 2006

PROGRESS REPORT CORAMSINE PHASE II CANCER TRIALS
Click here for PDF
MORE...

Tuesday, 31 January 2006

SOLBEC ANNOUNCES GRANT OF NEW ZEALAND PATENT
Click here for PDF
MORE...

Friday, 13 January 2006

SOLBEC ANNOUNCES GRANT OF US PATENT
Click here for PDF 
MORE...

Friday, 23 December 2005

88 PERCENT TAKE UP ON SOLBECS OFFER TO EXCHANGE OPTIONS FOR SHARES
Click here for PDF
MORE...

Tuesday, 20 December 2005

SOLBEC SECURES OFFER FOR $2.26M COMMERCIAL READY GRANT FUNDING
Click here for PDF
MORE...